Skip to content

Enlite® Sensor MMT-7008A

by Medtronic Minimed, Inc.

Enlite Sensor MMT-7008A is a medical device (FDA Class III; FDA product code OZO, Artificial pancreas device system, threshold suspend) made by Medtronic Minimed, Inc., approved under FDA PMA P120010 on 26 Sep 2013 and listed in FDA GUDID since 19 Sep 2016 (UDI-DI 20643169646432), active as of 23 Oct 2026. One FDA recall is linked to it.

Active United States. Also listed in GUDID (US).

PMA

Valid until

No expiry

PMA approval is not time-limited

FDA recalls

1 ongoing

This device is named in the recall

Documents

PMA P120010

FDA submission, from GUDID

Trust

Unverified

Source GUDID, synced 23 Oct 2026.

Regulatory status

as of registry sync 23 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesGUDID listing Number20643169646432 UDI-DI Date19 Sep 2016ListedStatusListed GUDID: in commercial distribution
United StatesFDA PMAAPPR from GUDID Approved NumberP120010 Date26 Sep 2013DecidedStatusActive

Official records

From the FDA record

Device description
SENSOR MMT-7008A ENLT PLUS 5PK 2L 1CL PR
MRI safety
MR Conditional
Natural rubber latex
No latex statement on the label
Sterility
Supplied sterile

From the GUDID record (AccessGUDID), as read on 23 Oct 2026, as the labeller entered it.

Across registries

2 registries list this device

  • FDA PMA P120010 decided 26 Sep 2013 Active
  • FDA GUDID UDI-DI 20643169646432 listed 19 Sep 2016 Listed

Recalls

2 recalls · 1 ongoing · FDA

    • Ongoing Z-1751-2026 FDA Class II initiated 13 Feb 2026

    All Medtronic MiniMed infusion pumps (Paradigm series, 600 series, and BLE 700 series) were found to be affected by unintended over- and under-delivery of insulin when the pump is elevated or lowered relative to the infusion site, respectively, because of changes in gravitational force impacting hydrostatic and hydrodynamic pressures. Insulin over-delivery, which can occur when the pump is elevated relative to the infusion site, can result in severe hypoglycemia, altered mental status, seizure, coma, or death. An under-delivery of insulin, which can occur at lowered pump height conditions relative to the infusion site, can result in severe hyperglycemia, dehydration, diabetic ketoacidosis, or death.

    • Terminated Z-2544-2014 FDA Class II initiated 13 Mar 2014 on shared PMA P120010

    Medtronic is recalling the Medtronic MiniMed Paradigm Insulin Infusion Pumps because they have received reports that users have accidentally programmed the pump to deliver the maximum bolus amount.

Recalls on a shared submission name another device cleared under the same FDA submission as this one.

Timeline

4 dated events

  1. Approved FDA PMA P120010
  2. Recall initiated FDA recalls Z-2544-2014
  3. Listed FDA GUDID 20643169646432
  4. Recall initiated FDA recalls Z-1751-2026

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA PMA Active

Specification

GUDID

Trade name
Enlite® Sensor
Generic name
Percutaneous interstitial fluid glucose monitoring system sensor
Model / reference
MMT-7008A
Primary DI / UDI-DI
20643169646432
PMA number
FDA product code
OZO
GMDN term
Percutaneous interstitial fluid glucose monitoring system sensor
Device class
Class III
GUDID distribution status
In Commercial Distribution
MRI safety
MR Conditional

Similar devices

Other devices filed under FDA product code OZO (Artificial pancreas device system, threshold suspend).

Other devices from Medtronic Minimed, Inc.

See all devices from Medtronic Minimed, Inc. →

Properties

  • Supplied sterile
  • Single use
  • Prescription use
  • Lot / batch number
Other properties (11, all answered No)